NO20055173L - Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel - Google Patents

Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel

Info

Publication number
NO20055173L
NO20055173L NO20055173A NO20055173A NO20055173L NO 20055173 L NO20055173 L NO 20055173L NO 20055173 A NO20055173 A NO 20055173A NO 20055173 A NO20055173 A NO 20055173A NO 20055173 L NO20055173 L NO 20055173L
Authority
NO
Norway
Prior art keywords
combination
modafinil
another drug
pharmaceutical
pharmaceutical combination
Prior art date
Application number
NO20055173A
Other languages
English (en)
Other versions
NO20055173D0 (no
Inventor
Jeffrey L Vaught
Rodney J Hughes
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of NO20055173D0 publication Critical patent/NO20055173D0/no
Publication of NO20055173L publication Critical patent/NO20055173L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Preparater og fremgangsmåter for behandling av lidelser ved administrering av modafinil med M-droger.
NO20055173A 2003-05-16 2005-11-03 Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel NO20055173L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47130203P 2003-05-16 2003-05-16
US10/845,836 US20040229943A1 (en) 2003-05-16 2004-05-14 Analeptic and drug combinations
PCT/US2004/015408 WO2004103359A1 (en) 2003-05-16 2004-05-17 Pharmaceutical combination comprising modafinil and another drug

Publications (2)

Publication Number Publication Date
NO20055173D0 NO20055173D0 (no) 2005-11-03
NO20055173L true NO20055173L (no) 2005-12-12

Family

ID=33424098

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055173A NO20055173L (no) 2003-05-16 2005-11-03 Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel

Country Status (14)

Country Link
US (1) US20040229943A1 (no)
EP (1) EP1635807A1 (no)
JP (1) JP2007506801A (no)
KR (1) KR20060015727A (no)
AU (1) AU2004241110A1 (no)
BR (1) BRPI0411176A (no)
CA (1) CA2524870A1 (no)
EA (1) EA200501821A1 (no)
IS (1) IS8099A (no)
MX (1) MXPA05012358A (no)
MY (1) MY135829A (no)
NO (1) NO20055173L (no)
TW (1) TW200509896A (no)
WO (1) WO2004103359A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2168946A1 (en) * 2000-07-27 2010-03-31 Teva Pharmaceutical Industries Ltd Crystalline form of modafinil, and methods of preparing the crystalline form
US20070053976A1 (en) * 2002-05-17 2007-03-08 Eisai R & D Management Co., Ltd. Novel combination of drugs as antidepressant
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
WO2005099822A2 (en) * 2004-04-13 2005-10-27 Cephalon, Inc. Reduction of drug / drug interactions with modafinil
ATE488275T1 (de) * 2006-03-23 2010-12-15 Yissum Res Dev Co Verwendung von digitalis-artigen verbindungen bei der behandlung von affektiven störungen
DE102006015734A1 (de) * 2006-04-04 2007-10-11 Hermann, Holger Lars, Dr. Kombinationspräparate aus Modafinil, Ritalin und Topiramat und deren Derivaten zur Behandlung von Kokainabhängigkeit und/oder Impulskontrollstörung
US20080131491A1 (en) * 2006-12-01 2008-06-05 Akinori Hanatani Percutaneously absorbable preparation
WO2008066185A1 (fr) * 2006-12-01 2008-06-05 Nitto Denko Corporation Procédé destiné à prévenir la décoloration provoquée par le temps d'une préparation d'adhésif cutané contenant du donépézil
WO2009145269A1 (ja) * 2008-05-30 2009-12-03 エーザイ・アール・アンド・ディー・マネジメント株式会社 経皮吸収製剤
US20110056863A1 (en) * 2008-05-30 2011-03-10 Junichi Sekiya Adhesive preparation containing donepezil, and package of the same
KR20120101588A (ko) * 2010-01-07 2012-09-13 비버스 인크. 탄산탈수효소 억제제 및 추가적인 활성제의 조합에 의한 폐쇄 수면 무호흡 증후군의 치료
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696153A (en) * 1994-05-16 1997-12-09 Napro Biotherapeutics, Inc. Therapeutic regimen for treating patients
FR2771004B1 (fr) * 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
AU6528400A (en) * 1999-08-23 2001-03-19 David M. Ockert Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
US20010034373A1 (en) * 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
US6417184B1 (en) * 2000-09-19 2002-07-09 David M. Ockert Triple drug therapy for the treatment and prevention of acute or chronic pain
US20030036555A1 (en) * 2001-08-03 2003-02-20 Boehringer Ingelheim Pharma Kg Pramipexole for the treatment of ADHD
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos

Also Published As

Publication number Publication date
EA200501821A1 (ru) 2006-06-30
WO2004103359A1 (en) 2004-12-02
JP2007506801A (ja) 2007-03-22
AU2004241110A1 (en) 2004-12-02
CA2524870A1 (en) 2004-12-02
KR20060015727A (ko) 2006-02-20
EP1635807A1 (en) 2006-03-22
US20040229943A1 (en) 2004-11-18
BRPI0411176A (pt) 2006-07-18
MY135829A (en) 2008-07-31
TW200509896A (en) 2005-03-16
IS8099A (is) 2005-10-27
MXPA05012358A (es) 2006-02-02
NO20055173D0 (no) 2005-11-03

Similar Documents

Publication Publication Date Title
NO20055173L (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
BRPI0415858A (pt) compostos de medicamentos terapêuticos modificados por tocoferol
ITMI20041317A1 (it) Formulazioni farmaceutiche per la somministrazione sicura di farmaci utilizzati nel trattamento della tossicodipendenza e procedimento per il loro ottenimento
NO20071751L (no) Fremgangsmater og kit for levering av legemidler ved nebulisering
NO20053224D0 (no) Patient controlled drug administration device.
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
IS7076A (is) Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni
NO20051966L (no) Nye pyrimidinamidderivater og anvendelse derav
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
EA200401252A1 (ru) Микрочастицы лекарственных веществ
DE602004000260D1 (de) Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen
ATE411022T1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
NO20092527L (no) Prolegemidler, fremgangsmate for fremstilling og anvendelse derav
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
DK1032376T3 (da) Anvendelse af benzhydrylsulfinylderivater til behandling af søvnighed af medicinal oprindelse
NO20055838L (no) Aktive varianter av IL-18 bindende protein og medisinske anvendelser derav
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
ATE432068T1 (de) Cetirizin und pseudoephedrin enthaltende tablette
NO20051159L (no) Preparater og fremgangsmater for behandling av sykdommer som viser feilsammensetting av aggregering av protein
DE60321572D1 (de) Transdermales arzneimittelverabreichungssystem
DK1696913T3 (da) Vinfluninholdigt farmaceutisk præparat til parenteral administration, fremgangsmåde til fremstilling deraf og dets anvendelse
NO20075508L (no) Stannsoporfinpreparater og administrering
MA31227B1 (fr) Composition pharmaceutique renfermant du phloroglucinol et du paracetamol.
EA200602199A1 (ru) Композиции, содержащие глюкозаминогликан и нестероидное противовоспалительное средство
PT1242092E (pt) Combinacao de farmacos para o tratamento da dor de cabeca que compreende mirtazapina e paracetamol ou um farmaco nao esteroide anti-inflamatorio